01 2Clarinex
02 4Clarinex
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2021 Revenue in Millions : 111
2020 Revenue in Millions : 130
Growth (%) : -15
Main Therapeutic Indication : Respiratory Diseases
Currency : USD
2022 Revenue in Millions : 125
2021 Revenue in Millions : 111
Growth (%) : 13
Main Therapeutic Indication : Respiratory Diseases
Currency : USD
2023 Revenue in Millions : 136
2022 Revenue in Millions : 125
Growth (%) : 9
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2015 Revenue in Millions : 232
2014 Revenue in Millions : 187
Growth (%) : -19%
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2014 Revenue in Millions : -1.30%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2016 Revenue in Millions : Not Reported
2015 Revenue in Millions : 187
Growth (%) : -100
LOOKING FOR A SUPPLIER?